Katarina Luptakova's Insider Trades & SAST Disclosures

Katarina Luptakova's most recent trade in Xilio Therapeutics Inc was a trade of 200,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 1, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Xilio Therapeutics Inc
Katarina Luptakova CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 200,000 200,000 - - Stock Option (right to buy)
Xilio Therapeutics Inc
Katarina Luptakova CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2025 16,625 16,625 - - Common Stock
Xilio Therapeutics Inc
Katarina Luptakova CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2025 16,625 49,875 - - Restricted Stock Units
Xilio Therapeutics Inc
Katarina Luptakova CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2024 59,333 59,333 - - Stock Option (right to buy)
Xilio Therapeutics Inc
Luptakova Katarina CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 66,500 66,500 - - Restricted Stock Units
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades